Kawin Technology(SH:688687)2026-01-30 08:15Financial Performance Forecast - The company expects a net profit attributable to shareholders of between 26 million and 38 million yuan for 2025, a decrease of 10.44 million to 11.64 million yuan compared to the previous year, representing a year-on-year decline of 73.31% to 81.74%[1] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 20 million and 30 million yuan, down by 10.70 million to 11.70 million yuan from the previous year, indicating a year-on-year decrease of 78.10% to 85.40%[1] - The total profit for the year 2024 was 176.83 million yuan, with a net profit attributable to shareholders of 142.37 million yuan[2] - The net profit after deducting non-recurring gains and losses for 2024 was 136.98 million yuan, with earnings per share of 0.85 yuan[2] Reasons for Performance Change - The primary reason for the performance change is the significant asset impairment provision due to the withdrawal of a drug registration application, which led to a full impairment of the related development expenses[3][4] - Excluding the impact of the asset impairment, the company's net profit for 2025 is expected to remain stable compared to the previous year, with steady development in core business operations[4] Forecast Validity and Audit Status - The performance forecast is based on preliminary calculations by the company's finance department and has not been audited by a registered accountant[5] - As of the announcement date, the company has not identified any significant uncertainties that could affect the accuracy of the performance forecast[5] - The forecast data is preliminary and the final audited financial data will be disclosed in the official 2025 annual report[6]